Hirva Mamdani
Wayne State University(US)The Barbara Ann Karmanos Cancer Institute(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Lung Cancer Research Studies, Cancer Genomics and Diagnostics, Economic and Financial Impacts of Cancer
Most-Cited Works
- → Immunotherapy in Lung Cancer: Current Landscape and Future Directions(2022)356 cited
- → Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline(2022)120 cited
- → Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline(2022)110 cited
- → Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope?(2020)77 cited
- → Blood-based tumor biomarkers in lung cancer for detection and treatment(2017)73 cited
- → Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies(2021)56 cited
- → Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-Label, Phase 2 Trial (Cohort 4)(2023)49 cited
- → Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.1(2023)49 cited
- → Interim results of an ongoing phase 1/2a study of HPN328, a tri-specific, half-life extended, DLL3-targeting, T-cell engager, in patients with small cell lung cancer and other neuroendocrine cancers.(2022)45 cited
- → Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer(2023)41 cited